Latest Insider Transactions at Amicus Therapeutics, Inc. (FOLD)
This section provides a real-time view of insider transactions for Amicus Therapeutics, Inc. (FOLD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AMICUS THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AMICUS THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
22,000
-2.45%
|
$220,000
$10.26 P/Share
|
|
Jun 15
2021
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+2.39%
|
$88,000
$4.38 P/Share
|
|
Jun 10
2021
|
Eiry Roberts |
BUY
Grant, award, or other acquisition
|
Direct |
22,759
+50.0%
|
-
|
|
Jun 10
2021
|
Craig A Wheeler |
BUY
Grant, award, or other acquisition
|
Direct |
10,115
+24.53%
|
-
|
|
Jun 10
2021
|
Burke W Whitman |
BUY
Grant, award, or other acquisition
|
Direct |
10,115
+14.94%
|
-
|
|
Jun 10
2021
|
Michael Raab |
BUY
Grant, award, or other acquisition
|
Direct |
10,115
+21.58%
|
-
|
|
Jun 10
2021
|
Michael Aaron Kelly |
BUY
Grant, award, or other acquisition
|
Direct |
10,115
+34.8%
|
-
|
|
Jun 10
2021
|
Lynn Dorsey Bleil |
BUY
Grant, award, or other acquisition
|
Direct |
10,115
+14.34%
|
-
|
|
Jun 10
2021
|
Margaret G Mcglynn |
BUY
Grant, award, or other acquisition
|
Direct |
10,115
+21.01%
|
-
|
|
Jun 10
2021
|
Glenn Sblendorio |
BUY
Grant, award, or other acquisition
|
Direct |
10,115
+18.68%
|
-
|
|
Jun 10
2021
|
Robert Essner Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,115
+24.53%
|
-
|
|
Jun 07
2021
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
10,514
-2.25%
|
$105,140
$10.01 P/Share
|
|
Jun 07
2021
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
73,110
+2.6%
|
$219,330
$3.71 P/Share
|
|
Jun 07
2021
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,350
-3.66%
|
$173,500
$10.08 P/Share
|
|
Jun 07
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
29,500
-3.25%
|
$295,000
$10.01 P/Share
|
|
Jun 07
2021
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+1.19%
|
$110,000
$5.42 P/Share
|
|
Jun 01
2021
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+3.06%
|
$13,500
$9.24 P/Share
|
|
May 25
2021
|
Lynn Dorsey Bleil |
BUY
Open market or private purchase
|
Direct |
28,605
+36.25%
|
$228,840
$8.74 P/Share
|
|
May 18
2021
|
Michael Raab |
BUY
Exercise of conversion of derivative security
|
Direct |
5,634
+17.46%
|
$39,438
$7.56 P/Share
|
|
May 03
2021
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
10,514
-2.49%
|
$105,140
$10.27 P/Share
|
|
May 03
2021
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,514
+2.43%
|
$63,084
$6.45 P/Share
|
|
May 03
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
7,500
-0.84%
|
$75,000
$10.28 P/Share
|
|
May 03
2021
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+3.16%
|
$15,000
$10.21 P/Share
|
|
May 03
2021
|
Margaret G Mcglynn |
SELL
Open market or private sale
|
Direct |
10,000
-26.37%
|
$100,000
$10.27 P/Share
|
|
May 03
2021
|
Margaret G Mcglynn |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+20.87%
|
$70,000
$7.51 P/Share
|
|
Apr 22
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
7,683
-0.85%
|
$76,830
$10.01 P/Share
|
|
Apr 15
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
22,000
-2.39%
|
$220,000
$10.09 P/Share
|
|
Apr 15
2021
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+2.33%
|
$132,000
$6.45 P/Share
|
|
Apr 15
2021
|
Samantha Prout Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
660
-0.74%
|
$6,600
$10.33 P/Share
|
|
Apr 15
2021
|
Samantha Prout Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,201
+21.4%
|
-
|
|
Apr 06
2021
|
Ellen Rosenberg Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,501
+7.83%
|
-
|
|
Apr 06
2021
|
Daphne Quimi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,295
+6.23%
|
-
|
|
Apr 06
2021
|
Bradley L Campbell President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
33,165
+7.45%
|
-
|
|
Apr 06
2021
|
John F Crowley Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
78,389
+8.01%
|
-
|
|
Apr 06
2021
|
Hung Do Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,501
+4.37%
|
-
|
|
Apr 06
2021
|
David Michael Clark Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,883
+8.83%
|
-
|
|
Apr 01
2021
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+3.26%
|
$15,000
$10.0 P/Share
|
|
Apr 01
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
7,500
-0.9%
|
$75,000
$10.0 P/Share
|
|
Apr 01
2021
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
10,514
-2.7%
|
$105,140
$10.03 P/Share
|
|
Apr 01
2021
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,514
+2.63%
|
$63,084
$6.45 P/Share
|
|
Mar 26
2021
|
Samantha Prout Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
435
-0.67%
|
$3,915
$9.59 P/Share
|
|
Mar 22
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
7,682
-0.92%
|
$76,820
$10.29 P/Share
|
|
Mar 15
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
22,000
-2.56%
|
$220,000
$10.77 P/Share
|
|
Mar 15
2021
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+2.5%
|
$132,000
$6.45 P/Share
|
|
Mar 05
2021
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,664
-1.69%
|
$46,640
$10.48 P/Share
|
|
Mar 05
2021
|
Daphne Quimi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,628
+5.68%
|
$33,256
$2.94 P/Share
|
|
Mar 01
2021
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+3.37%
|
$18,000
$12.4 P/Share
|
|
Mar 01
2021
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
10,514
-2.7%
|
$115,654
$11.84 P/Share
|
|
Mar 01
2021
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,514
+2.63%
|
$63,084
$6.45 P/Share
|
|
Mar 01
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
7,500
-0.89%
|
$82,500
$11.85 P/Share
|